{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T11:27:22Z","timestamp":1786879642205,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000028","name":"Institute of Circulatory and Respiratory Health","doi-asserted-by":"publisher","award":["TCA 118349"],"award-info":[{"award-number":["TCA 118349"]}],"id":[{"id":"10.13039\/501100000028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["G-15-0009034"],"award-info":[{"award-number":["G-15-0009034"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021570","name":"Strategy for Patient-Oriented Research","doi-asserted-by":"publisher","award":["MYG 151211"],"award-info":[{"award-number":["MYG 151211"]}],"id":[{"id":"10.13039\/100021570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012665","name":"Institute for Clinical Evaluative Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025092","name":"Ministry of Health, Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000222","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN 143313"],"award-info":[{"award-number":["FDN 143313"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["DA6-184677"],"award-info":[{"award-number":["DA6-184677"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025090","name":"Ministry of Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cjca.2026.06.027","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:13:05Z","timestamp":1783120385000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neighborhood-Level Material Resources and Risk of Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease"],"prefix":"10.1016","author":[{"given":"Maya S.","family":"Sheth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalane","family":"Basque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiming","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace D.","family":"McNaughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis T.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Abdel-Qadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7402-9584","authenticated-orcid":false,"given":"Jacob A.","family":"Udell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2026.06.027_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004416","article-title":"Cardiovascular disease burden and socioeconomic correlates: findings from the Jackson Heart Study","volume":"6","author":"Min","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2026.06.027_bib2","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jamaneurol.2020.2494","article-title":"New horizons in pharmacologic therapy for secondary stroke prevention","volume":"77","author":"Katsanos","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.cjca.2026.06.027_bib3","first-page":"1129","article-title":"2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2026.06.027_bib4","first-page":"151","article-title":"2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"29","author":"Anderson","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2026.06.027_bib5","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.06.027_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jcjd.2020.08.001","article-title":"Pharmacologic glycemic management of type 2 diabetes in adults: 2020 update","volume":"44","author":"Lipscombe","year":"2020","journal-title":"Can J Diabetes"},{"issue":"Suppl 1","key":"10.1016\/j.cjca.2026.06.027_bib7","first-page":"S111","article-title":"Pharmacologic approaches to glycemic treatment:standards of care in Diabetes\u20132026","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cjca.2026.06.027_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2024-004431","article-title":"Recent trends in GLP-1 RA and SGLT2i use among people with type 2 diabetes and atherosclerotic cardiovascular disease in the USA","volume":"12","author":"King","year":"2024","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.cjca.2026.06.027_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12933-020-01154-w","article-title":"Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes","volume":"19","author":"Schernthaner","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cjca.2026.06.027_bib10","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.2174\/1381612820666140620162629","article-title":"Statin treatment non-adherence and discontinuation: clinical implications and potential solutions","volume":"20","author":"Phan","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.cjca.2026.06.027_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026582","article-title":"Global burden, regional differences, trends, and health consequences of medication nonadherence for hypertension during 2010 to 2020: a meta-analysis involving 27 million patients","volume":"11","author":"Lee","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"Suppl 1","key":"10.1016\/j.cjca.2026.06.027_bib12","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.2105\/AJPH.2010.191619","article-title":"The science of eliminating health disparities: summary and analysis of the NIH summit recommendations","volume":"100","author":"Dankwa-Mullan","year":"2010","journal-title":"Am J Public Health"},{"key":"10.1016\/j.cjca.2026.06.027_bib13","series-title":"CCO and Ontario Agency for Health Protection and Promotion","author":"Chu","year":"2019"},{"key":"10.1016\/j.cjca.2026.06.027_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.6139","article-title":"Association of race\/ethnicity, gender, and socioeconomic status with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in the US","volume":"4","author":"Eberly","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cjca.2026.06.027_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2021.4182","article-title":"Racial, ethnic, and socioeconomic inequities in glucagon-like peptide-1 receptor agonist use among patients with diabetes in the US","volume":"2","author":"Eberly","year":"2021","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.cjca.2026.06.027_bib16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/jama.2022.13885","article-title":"Association of race and ethnicity with prescription of SGLT2 inhibitors and GLP1 receptor agonists among patients with type 2 diabetes in the Veterans Health Administration System","volume":"328","author":"Lamprea-Montealegre","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2026.06.027_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2337\/dc22-0383","article-title":"Deficits and disparities in early uptake of glucagon-like peptide 1 receptor agonists and SGLT2i among Medicare-insured adults following a new diagnosis of cardiovascular disease or heart failure","volume":"46","author":"Cromer","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cjca.2026.06.027_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.16290","article-title":"Association of prescription co-payment with adherence to glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter-2 inhibitor therapies in patients with heart failure and diabetes","volume":"6","author":"Essien","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cjca.2026.06.027_bib19","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.2337\/dc19-1536","article-title":"Universal drug coverage and socioeconomic disparities in health care costs among persons with diabetes","volume":"43","author":"Isaranuwatchai","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cjca.2026.06.027_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1503\/cmaj.070587","article-title":"Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures","volume":"178","author":"Demers","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.cjca.2026.06.027_bib21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/CIRCOUTCOMES.114.001416","article-title":"The Cardiovascular Health in Ambulatory Care Research Team (CANHEART): using big data to measure and improve cardiovascular health and healthcare services","volume":"8","author":"Tu","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cjca.2026.06.027_bib22","article-title":"Current utilization patterns of glucagon-like peptide-1 receptor agonists","volume":"2","author":"Vannabouathong","year":"2022","journal-title":"Can J Health Technol"},{"key":"10.1016\/j.cjca.2026.06.027_bib23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.17269\/s41997-021-00552-1","article-title":"The 2011 and 2016 iterations of the Ontario Marginalization Index: updates, consistency and a cross-sectional study of health outcome associations","volume":"113","author":"van Ingen","year":"2022","journal-title":"Can J Public Health"},{"key":"10.1016\/j.cjca.2026.06.027_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCULATIONAHA.122.058949","article-title":"Association of neighborhood-level material deprivation with atrial fibrillation care in a single-payer health care system: a population-based cohort study","volume":"146","author":"Abdel-Qadir","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.06.027_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.123.010063","article-title":"Association of neighborhood-level marginalization with health care use and clinical outcomes following hospital discharge in patients who underwent coronary catheterization for acute myocardial infarction in a single-payer health care system","volume":"16","author":"Akioyamen","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cjca.2026.06.027_bib26","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/ejhf.3090","article-title":"Association of neighbourhood-level material deprivation with adverse outcomes and processes of care among patients with heart failure in a single-payer healthcare system: a population-based cohort study","volume":"25","author":"Bobrowski","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2026.06.027_bib27","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1056\/NEJMsa1107913","article-title":"Full coverage for preventive medications after myocardial infarction","volume":"365","author":"Choudhry","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2026.06.027_bib28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.06.027_bib29","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1089\/heq.2022.0063","article-title":"Systematic review: impact of social determinants of health on the management and prognosis of gallstone disease","volume":"6","author":"Dupont","year":"2022","journal-title":"Health Equity"},{"key":"10.1016\/j.cjca.2026.06.027_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12872-017-0495-4","article-title":"Exploring the impact of financial barriers on secondary prevention of heart disease","volume":"17","author":"Dhaliwal","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"issue":"11 Suppl 1","key":"10.1016\/j.cjca.2026.06.027_bib31","first-page":"S219","article-title":"Full prescription coverage versus usual prescription coverage after coronary artery bypass graft surgery: analysis from the post-myocardial infarction free Rx event and economic evaluation (FREEE) randomized trial","volume":"128","author":"Kulik","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.06.027_bib32","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCULATIONAHA.123.064188","article-title":"Eliminating medication copayments for low-income older adults at high cardiovascular risk: a randomized controlled trial","volume":"147","author":"Campbell","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.06.027_bib33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jacc.2015.05.030","article-title":"Utilization of and adherence to guideline-recommended lipid-lowering therapy after acute coronary syndrome: opportunities for improvement","volume":"66","author":"Hirsh","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2026.06.027_bib34","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s13300-019-0615-5","article-title":"GLP-1 RA treatment and dosing patterns among type 2 diabetes patients in six countries: a retrospective analysis of pharmacy claims data","volume":"10","author":"Divino","year":"2019","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.cjca.2026.06.027_bib35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2337\/dsi22-0003","article-title":"Equity in medical care for people living with diabetes","volume":"35","author":"Garcia","year":"2022","journal-title":"Diabetes Spectr"},{"key":"10.1016\/j.cjca.2026.06.027_bib36","first-page":"3","article-title":"Self-reported financial barriers to care among patients with cardiovascular-related chronic conditions","volume":"25","author":"Campbell","year":"2014","journal-title":"Health Rep"},{"key":"10.1016\/j.cjca.2026.06.027_bib37","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cardfail.2021.07.001","article-title":"Language matters: understanding barriers to medication adherence to better tailor heart failure care","volume":"27","author":"Lala","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.cjca.2026.06.027_bib38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pec.2014.07.017","article-title":"Understanding patient perceptions of shared decision making","volume":"96","author":"Shay","year":"2014","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.cjca.2026.06.027_bib39","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/jch.13089","article-title":"Disparities in hypertension and cardiovascular disease in blacks: the critical role of medication adherence","volume":"19","author":"Ferdinand","year":"2017","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.cjca.2026.06.027_bib40","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/CIRCULATIONAHA.123.064189","article-title":"Self-management support using advertising principles for older adults with low income at high cardiovascular risk: a randomized controlled trial","volume":"147","author":"Campbell","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2026.06.027_bib41","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2023.2854","article-title":"Coordinated care to optimize cardiovascular preventive therapies in type 2 diabetes: a randomized clinical trial","volume":"329","author":"Pagidipati","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2026.06.027_bib42","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.cjco.2022.05.010","article-title":"Access to cardiovascular care for Indigenous Peoples in Canada: a rapid review","volume":"4","author":"Vervoort","year":"2022","journal-title":"CJC Open"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X26006495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X26006495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T11:06:21Z","timestamp":1786878381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X26006495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":42,"alternative-id":["S0828282X26006495"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2026.06.027","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neighborhood-Level Material Resources and Risk of Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2026.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}